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OUR EXPERIENCE WITH THE 
MANAGEMENT OF POSTERIOR URETHRAL 
VALVE
A REVIEW OF 104 CASES
INTRODUCTION
Posterior  urethral  valve  (P.U.V)  represents  the  most  common  cause  of  congenital 
obstructive  uropathy  leading  to  childhood  renal  failure.  The  incidence  of  P.U.V.  is 
approximately  1:5000  to  1:8000  infant  males24,27.  Challenges  posed  by  children  with 
P.U.V are multiple. Obstruction by valves is a process which involves the entire urinary 
system. So the surgeons involved in the acute and long-term care of these patients are 
faced with the challenging management problems that are multiple and interdependent.
Appropriate  clinical  suspicion  remains  the  key  to  diagnosis  which  is  confirmed  by 
standard imaging techniques. Initial therapy usually consists of skillful endoscopic work 
to remove the obstruction24. The outcome is however far from determined at this point. 
The risk of renal compromise and ultimate renal failure is a potential problem for each 
patient. This outcome may be altered by appropriate intervention, but in most cases the 
renal development in utero determines the need for eventual dialysis or transplant. 
In the past, the treatment of P.U.V was based primarily on the mechanism of obstruction 
and its relief. The current treatment of P.U.V. is based upon our evolving knowledge of 
the  consequences  of  bladder  outlet  obstruction  on  our  patients  renal  health  and  is 
enhanced by continuous, long term follow-up.
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AIMS OF THE STUDY 
1. TO ANALYZE OUR EXPERIENCE WITH THE MANAGEMENT OF PUV AND 
TO  STUDY  THE  SHORT  TERM  OUTCOME OF  PATIENTS  MANAGED  AT 
OUR INSTITUTION.
2. TO  ANALYZE  THE  DIFFERENT  MODALITIES  OF  TREATMENT  AND  TO 
CHOOSE THE BEST AMONG THEM.
3. TO  DETERMINE  THE COMPLICATIONS  AND  FOLLOW-UP  CRITERIA  OF 
PUV.
4. TO  DETERMINE  THE  PROGNOSIS  OF  OUR  ANTENATALLY  DETECTED 
PATIENTS.        
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MATERIALS AND METHODS
Study Type : Retrospective and 
prospective study
Study Group : 104 patients of P.U.V 
were analyzed  regarding presenting symptoms, 
signs  and  the different  modalities  of  treatment 
instituted 
Study Period : January 1998 to 
January 2007 (9 years)
Study Center : Coimbatore Medical 
College & Hospital, Coimbatore-18.
METHODOLOGY 
In our study of 104 patients of P.U.V, 34 (32.70%) cases presented in the neonatal period, 
31 (29.80%) cases  between 1 to 12 months of  age , 24 (23.08%) patients in the 1 to 5 
year age group and 15 (14.42%) were of 5 to 12 years of age. 8 patients were diagnosed 
antenatally.
Among the 104 patients, 47 were treated by Primary endoscopic valve fulguration and the 
remaining cases underwent urinary diversion either in the form of vesicostomy in 45 
patients or ureterostomy in 9 patients. We have analyzed the results and have presented 
the discussion with a brief review of literature, follow-up and recommendations.  
7
MANAGEMENT 
Our patients were grouped as follows
Group General Condition Infection Urea & Creatinine
Group-1 Good Absent Normal
Group-2 Poor Absent High
Group-3 Poor Present High
TABLE – 1
GROUP DISTRIBUTION
Group No. of Patients Percentage
Group-I 35 34.65
Group-II 20 19.80
Group-III 46 45.55
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POSTERIOR URETHRAL VALVE
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RESULTS
Study was carried out over a period of 9 years from January 1998 to January 
2007.  Patients were followed up monthly after intervention.
DEMOGRAPHY:
Total number of cases : 104
Age : Birth till 12 years
Duration of Symptoms : 1 Day to 5 years
Duration of Follow-up : 3 Months to 7 years
AGE DISTRIBUTION 
104 patients  came to our department  from between January 1998 to January 2007 (9 
years). 34 were neonates, 31 were in 1-12 month.age group, 24 were in 1- 5year age 
group and 15 were in 5-12 year. age group. 8 presented primarily in 5-12 age group.  
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TABLE – 2 
AGE DISTRIBUTION
Age No. of Cases Percentage
New Born 34 32.70
1-12 months 31 29.80
1-5 years 24 23.08
5-12 years 15 14.42
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PRESENTATION: CLINICAL SYMPTOMS
78 patients  had voiding symptoms,  11 had urinary retention and 32 had urinary tract 
infection. Organisms isolated from them were predominally E.coli., proteus.  8 patients 
were admitted with sepsis.
TABLE – 3
PRESENTATION: CLINICAL SYMPTOMS
Symptoms No.  of Patients Percentage 
Voiding Symptoms 78 60.47
UTI 32 24.80
Urinary Retention 11 8.53
Sepsis 8 6.20
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PRESENTATION : SIGNS
On presentation bladder was palpable in 62 patients. In 11 patients kidneys were also 
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Sepsis
palpable. 
TABLE – 4
BLADDER PALPABILITY 
 Palpable Bladder No. of Patients Percentage 
Newborn 28 82.35
1-12 months 22 70.97
1-5 years 6 25
5-12 years 0 0.00
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TYPE OF VALVE AND CYSTOSCOPY FINDINGS 
Type-1 valve was seen in 96 patients, Type-3 valve was seen in 2 patients. In 3 patients 
cystoscopy  was  not  done.  In  3  patients  the  typical  valve  was  not  seen.   Bladder 
trabeculations and sacculations were seen in 38 patients and features of cystitis were seen 
in 22 patients. 
VALVE FREQUENCY
Valve Type No. of Patients Percentage 
Type-1 96 95.05
Type-2 0 0.00
Type-3 2 1.99
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PUV
POSTNATAL -ULTRASONOGRAM OF ABDOMEN – PUV
MICTURATING CYSTOURETHROGRAM – PUV
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TREATMENT – PRIMARY
Primary fulguration was done in 47 patients including 16 neonatal fulgurations.  Facilities 
for newborn fulguration have been available for the past 4 years.  54 diversions of which 
45 primary vesicostomies and 9 primary ureterostomies were also done.
TREATMENT DISTRIBUTION – PRIMARY
Types of Treatment No. of Cases Percentage
Primary Fulguration – 47 Patients
Newborns 16
1 month-12yrs 31
45.19
Diversion  – 54 Patients
Primary Vesicostomy 45
Primary Ureterostomy 9
54.81
Primary 
Fulguration, 47
Primary 
Vesicostomy, 
45
Primary 
Ureterostomy, 
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We  fulgurated  31  patients  after  diversion.   We  also  did  2  ureterostomies  and  1 
vesicostomy after fulguration. Initially dry fulguration was done in 22 of our patients. The 
present  policy is  to  do  simultaneous  fulguration  and diversion  closure  in  one  sitting, 
ultimately avoiding dry fulguration. 7 patients required refulguration for residual valve.
In  our  series  20  patients  were  catheterized  initially  for  stabilization.   Suprapubic 
cystostomy was done in 1 patient in a private hospital and referred .Also valvotome was 
used to check the adequacy of  fulguration in 5 patients.Fogarty's dilator was also used for 
the same in 10 patients. In 12 patients peritoneal dialysis had to be done to stabilize the 
general condition.
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URINARY TRACT INFECTIONS
Urinary tract  infection was seen in 32 of our patients during the initial  period before 
treatment and in 26 patients after intervention.  Organisms isolated were mostly E-coli 
and proteus.
AGE DISTRIBUTION – UTI 
Period Newborn 1mon-1yr 1-5 Years 5-12 Years
During Initial 
Presentation 9 10 10 3
After 
intervention 5 8 12 1
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OCCURRENCE OF VESICOURETERIC REFLUX 
Vesicoureteric reflux was seen in 22 of our patients of which 5 were newborns, 8 were in 
1mon. to 1yr. age group, 6 were in age group 1-5 years and 3 were in 5-12 years group.  
AGE DISTRIBUTION OF VUR
Age No. of Cases Percentage
Newborn 5 14.71
1mon-1yr 8 25.81
1-5 years 6 25.00
5-12 years 3 20.00
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Out of them 12 patients had bilateral VUR, 4 had reflux on the left and 6 had reflux on 
the right.
SIDE DISTRIBUTION OF VUR
Sides No. of Cases
Bilateral 12
Left 4
Right 6
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ASSOCIATED CONDITIONS
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MORTALITY
There were 16 deaths in our study.  7 were newborns, 8 were 1mon-1yr of age group and 
1 three and a half year old child. 
AGE DISTRIBUTION – MORTALITY
Age No. of Death Percentage
Newborn 7 20.59
1mon-1yr 8 25.81
1-5 years 1 4.17
5-12 years 0 00.00
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1-5 years
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1-12 Months
FOLLOW UP
Patients followed up with 
1. Monthly urine for culture and sensitivity
2. Quarterly blood urea and S. Creatinine
3.  MCU and USG if warranted
Of these followed up patients we had to repeat the fulguration for residual valves in 7 
patients.   We  also  did  2  ureterostomies  and  1  vesicostomy  after  fulguration.   Post 
operative stricture was seen in 7 of our patients and we had to do urethral dilatation. 
Some times they required repeated dilatations.   
18 patients were lost to follow up.  Now 67 patients are regularly on  follow up.  
To evaluate the morbidity we did radio nuclide studies (DTPA / DMSA) in 10 of them. 
Urodynamic  study  was  done  in  11  patients.   Subsequently  4  patients  underwent 
nephrectomy (2 open and 2 laparoscopic).  We also did reimplantation in 2 patients.  We 
did augmentation (Ureterocystoplasty) with Mitrofanoff procedure in one patient.  We 
also attemped STING procedure in 1 patient.
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PUV – RADIO NUCLEOTIDE STUDIES 
DTPA demonstrate radiotracer accumulation within the dilated renal collecting systems 
and dilated ureters. The bladder remains empty because of catheter drainage. 
DTPA  demonstrate  accumulation  of  radiotracer  within  the  renal  collecting  systems 
bilaterally; within the dilated ureters bilaterally; and within a small, irregular-appearing 
bladder. Renograms (bottom left) demonstrate poor clearance of contrast material from 
the renal collecting systems. The relatively poorer  function in the left  kidney reflects 
congenital renal dysplasia. 
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ANTENATALLY DETECTED PATIENTS 
Out of 8 patients detected antenatally 2 patients expired and 3 were lost to follow-up 
(probably expired).  Out of the remaining 3, 1 patient had nephrectomy and the other had 
ureterocele with VUR so reimplanted on one side and STING tried on another side.  Only 
one patient is at present without morbidity. 
The prognosis of antenatally detected patients has been dismal in our study.
LENGTH OF HOSPITAL – STAY
Finally the length of hospital stay for primary fulguration was on an average 7 to 10 days 
whereas for ureterostomy and closure the patient had to get admitted two times and total 
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length of stay was 15 to 20 days.  For vesicostomy and closure the average length of stay 
was 14 to 20 days for 2 admissions.  So therefore in our study the outcome of patients 
with PUV depended upon the initial renal status irrespective of the management options 
used.  So it is better to do fulguration primarily than diversion.  Fulguration is also cost 
effective, with lesser no. of surgeries , scarless and also economical for the Government.
LENGTH OF HOSPITAL – STAY
Primary Fulguration Ureterostomy / Closure Vesicostomy / Closure
10 days 22 days 18 days
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REVIEW OF LITERATURE
ANATOMY AND EMBRYOLOGY
Located in the posterior midportion of prostatic urethra is the verumontanum, containing 
paired ejaculatory duct openings and urogenital sinus remnant known as prostatic utricle. 
Extending distally from the veru in the midline is the crista-urethralis and diverging from 
this are the plicae colliculi, which merge into the membranous urethral area into 2 oblique 
folds.  Tolmatchew in1870 proposed these to be obstructing in some infants. Stephens 
postulates that these plicae are normal remnants of the terminal mesonephric ducts which 
regress during embryogenesis,  leaving only the ejaculatory duct openings.  Incomplete 
regression of the plicae leads to fusion dorsally to form the typical PUV. Stephens theory 
is supported by observations of twins with valves.  Livne et al suggests a mesonephric 
duct origin with possibility of polygenetic transmission and other undefined factors. B.W. 
Young maintains that P.U.V. obstruction represents abnormal development of urogenital 
sinus itself (persistence of the sino-vaginal bulb) and not the distal mesonephric duct4,10,11
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DEVELOPMENT OF TYPE – 1 VALVE 
DEVELOPMENT OF TYPE – 3 VALVE
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DISCUSSION 
CLASSIFICATION
Dr.H.Hampton  Young’s  long  standing  system  of  classification  is  still 
employed(1919)4,10,29,40.
In Type-1 valves are membranes that originate at the verumontanum and travels distally 
to insert in the anterior proximal membranous urethra with an opening present posteriorly 
at the verumontanum. The etiology is probably a result of the mesonephric ducts entering 
the cloaca more anteriorly than normal and fusing in the midline. Such valves offer no 
resistance to retrograde instrumentation but co-opt during micturition to obstruct urinary 
flow. It gives characteristic the sail-in-the wind finding in MCU.  
In Type-2 folds extend from upper extremity of verumontanum to bladder neck.  They 
are never obstructive and are of historical value only.
In Type-3 valves consist  of a ring-like membrane distal to the verumontanum with a 
perforation present centrally. Field and Stephens describe a variation of type 3 valves in 
which the membrane becomes stretched so that  during micturition it  prolapses  like a 
windsock, into bulbar urethra.  The cause of these valves is an incomplete dissolution of 
the urogenital membrane.95% of P.U.V. are type 1 with variations in leaflet thickness and 
in the degree of obliquity and coalasence at 12’O clock position.  The other 5% are type 
3. 
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Stephens  (1983)  suggested  type-4 valves  in  prune-belly  syndrome4 Exaggeration  of 
normal folds (plicae) without anterior fusion has been deemed partially obstructive by 
some (mini-valves).  Despite former classifications of PUV, Devan recently stated that 
most likely there is a single obstructive membrane that may be altered by the passage of 
urethral catheters or cystoscopes resulting in variable tears of the membrane. This may be 
perceived as Type I or III valve.  This concept of single type of valve is referred to as 
congenital obstructive posterior urethral membrane (COPUM)14
Also type 3 is referred as COBB’S COLLAR or MOORMAN’S RING (bulbar urethral 
obstruction)25.   We had  96  type  1  valve  patients  and  2  type  3  valve  patients  in  our 
cystoscopy findings.  
PATHOPHYSIOLOGY
Above the valves back-pressure effects are nearly always present. These take the form of 
a widely dilated posterior urethra, a thick walled and usually trabeculated bladder, widely 
dilated tortuous ureters and bilateral hydronephrosis. V.U.R is common and frequently 
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associated with varying degrees of dysplasia of affected kidney.                          
In the past, secondary narrowing at the bladder outlet was also felt to contribute to the 
obstruction in some cases. Y-V plasties and other operations directed to bladder neck 
were felt to be important.  This hypertrophy is now understood to be part of the overall 
detrusor wall thickening that results from the inferior obstruction, and needs no specific 
therapy, since it is not a true point of obstruction. Infact many children found to have 
stress  incontinence  later  in  life  have  undergone  a  concomitant  bladder  neck  ablative 
procedure. Since this approach has been abandoned, stress incontinence has eventually 
been eliminated.
Children with P.U.V manifest  renal abnormalities that  can include varying degrees of 
dysplasia or hydronephrosis. The renal abnormalities seen in these patients have atleast 
two theoretical etiologies, pressure and ureteral bud problems.  The first etiology states 
that the bladder pressure is related to the severity of original obstruction. Dysplasia & /or 
hydronephrosis develops, based on gestational timing and degree of pressure transmission 
to the upper tracts, by means of ureteral changes that follow unrelieved bladder pressure 
elevations. This occurs with or without breakdown of antireflux mechanism at the U.V 
junction. Mcguire has shown by his work in patients with myelomeningocele that chronic 
intravesical pressure of >40cms of water are associated with upper tract deterioration in a 
majority of patients. It seems likely that this same threshold is accurate in the fetus with 
valvular obstruction. Even in the absence of reflux, intrapelvic renal pressures reflect the 
underlying  high  pressure  bladder,  when  the  normal  urinary  system  is  first  filled  to 
capacity  with  urine.  GFR  decreases  in  a  similar  setting.  The  high  pressure  bladder 
therefore must play a key role in determining renal compromise but the initial pressure 
threshold or range that affects renal development in the fetus is yet to be determined.
The second theoretical etiology for renal abnormalities, ureteral bud induction problems, 
has been examined carefully by Henneberg & Stephens.  The severity of renal dysplasia 
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was correlating with the degree of ureteral orifice malposition. They deduced that the 
abnormality of the ureteral bud & metanephros interaction is causative4,11.
PRESENTATION 
Most children are now fortunate enough to be discovered on prenatal ultrasound and fetal 
MRI3,7,9. Treatment started early in life prevents the potential renal damage due to sepsis 
and pressure. At the other end of the spectrum are those fetuses with oligohydramnios, 
Potter facies and such severe pulmonary hypoplasia that even the most intense supportive 
measures  cannot  sustain  them.  Despite  the  fact  that  the  obstruction  is  the  primary 
problem, these infants may not be labeled as P.U.V patients because of severity of their 
pulmonary compromise and very early mortality.
More  than  half  of  the  children  with  P.U.V  are  discovered  in  neonatal  period.
(PUV=1:5000 to 8000 live male births) and 10% are detected prenatally. Presentation in 
the neonates includes distended bladder, bilateral flank masses, dribbling or weak urinary 
stream. However a full urinary stream doesn’t preclude significant urethral obstruction. 
Subtle signs of urethral obstruction can include failure to thrive and in some children it 
may be the only indication of underlying urinary difficulties. An acutely ill baby with 
P.U.V may have rapid respirations resulting from acidosis. Neonatal urinary ascites or 
urinary  extravasation  from  kidney  is  usually  considered  to  be  a  pressure  related 
phenomenon.
Infants in whom the diagnosis has been missed usually present with urinary infection and 
acute on chronic renal failure. This is generally accompanied by hyperkalemia and severe 
metabolic acidosis which may lead to respiratory arrest. Water and sodium balance are 
often  also profoundly disturbed.  Septicaemia is  common and may be complicated  by 
consumptive coagulopathy.
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Older boys may also present with urinary infection but often the main complaint is of a 
poor urinary stream with straining or urinary incontinence. It is important to maintain a 
high degree of suspicion until urinary abnormalities are excluded in such a child. The less 
severely affected child may be overlooked in the neonatal period. 
DIAGNOSIS & PROGNOSTIC SIGNS   
Antenatally, sonography and fetal MRI are useful in diagnosis.  In sonography the typical 
keyhole sign of bladder and urethral dilatation is seen.12,13,40 
In the newborn also, standard imaging studies usually provides an unequivocal diagnosis 
of posterior urethral obstruction. Sonography again is the preferred initial  study when 
obstruction is suspected, clinically and will show the typical hydroureteronephrosis, thick 
walled bladder and wide prostatic urethra associated with PUV.A loculated urinoma or 
urinary  ascites  can  also  be  identified.  The  MCU usually  confirms  the  diagnosis  and 
demonstrates  the  reflux  present  in  half  of  the  patients.  In  our  series  among  the  104 
patients 22 had reflux (bilateral -12 left – 4 and right – 6).  The dilated posterior urethra, 
hypertrophied bladder neck, and thick-walled sacculated bladder are typical features. At 
times this  typical appearance can be confused with Prune Belly syndrome in which a 
dilated posterior urethra narrows significantly at membranous urethra, but with a widely 
opened bladder neck and, sometimes with a urachal remnant.
In doubtful cases diagnosis can be confirmed by cysto-urethroscopy. Since valve cusps 
co-opt only during antegrade flow, they usually cannot be demonstrated during retrograde 
passage of  an  instrument.  The valve is  best  observed with the  bladder  filled  and the 
endoscope  placed  well  distal  to  the  veru  with  the  water  source  removed  and  the 
connection open. This allows irrigant to flow from the bladder through the instrument, 
bellowing the cusps demonstrating their coopting margins.
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Functional  assessment  of  the  kidneys  is  best  obtained  with  radionuclide  renography, 
allowing quantitation of renal function. As this test is not helpful in the first month and 
also if done in the first few days or prior to relief of obstruction, it offers very little help in 
clinical  management,  it  is postponed till  3-4 weeks. The extraction factor is  a simple 
calculation from the renogram, that reflects the GFR of the individual kidney, based on % 
uptake of radionuclide in each kidney during the 2-3 minutes of study. Bilateral VUR has 
usually been associated with both increased morbidity and decreased renal function.
Measure of nadir serum creatinine in the first few months after treatment has also proven 
to be a useful sign. If the lowest post treatment creatinine is <0.8mg/dl then renal function 
(with upto 8 years  of  follow-up) has  remained in  a normal  range.  Ducket  et  al  have 
recently shown that  there is  a  subset  of PUV patients  that  has a good renal function 
prognosis,  due  to  a  “POP-OFF” mechanism (Large  bladder  diverticulum,  VURD 
syndrome,  urinary  ascites,  patent  urachus).4,11,38.   Infants  with  VURD  syndrome 
(valves, unilateral reflux and dysplasia in a non-functioning unit) seems to spare the 
function of contralateral renal unit by a pressure “pop-off” mechanism which apparently 
protect the nephrons not subject to reflux. This group of patients has significantly better 
renal function as measured by serum creatinine.
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NATURE’S PRESSURE POP- OFF MECHANISMS 
 
PERIRENAL URINOMA
BLADDER DIVERTICULUM
UNILATERAL VUR
35
PROGNOSTIC VARIABLES  – ANTENATAL   4,11,25  
Variable Good predictors Poor predictors
In – utero presentation
( weeks)
> 24 <24
Amniotic fluid volume Normal to moderately 
increased
Moderate to severly 
decreased
Sonographic appearance of 
renal parenchyma
Normal to slightly 
increased echogenicity
Increased echogenicity 
to frankly cystic
Fetal urinary values
Sodium (mEq/L)
Chloride (mEq/L)
Osmolality (mOsm)
Urinary output (ml/Hr)
Beta 2 microglobulin
< 100
<90
<210
>2
<6
>100
>90
>210
<2
> 6
PROGNOSTIC VARIABLES – AFTER BIRTH
Variable Good predictors Poor predictors
Sonography – 
identification of CMJ 
differentiation
-Present
-Pyramids in atleast one 
kidney
-Absent
-Hyperechoic, no pyramids
S. Creatinine < 0.8 at one year >0.8 at one year
Reflux No reflux Bilateral reflux
Continence At 5 years incontinence
Pop off mechanisms
Urinary ascites
Bladder diverticulum
VURD
Patent urachus
Present
Present
Present
Present
Absent
Absent
Absent
Absent
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DIFFERENTIAL DIAGNOSIS 
A variety of other conditions may masquerade as PUV.  Prominent infra-collicular folds 
which can sometimes be made out on a good quality study in normal children. Hesitant 
voiding in a normal baby may cause an abrupt change in caliber of posterior urethra. 
Extrinsic compression by pelvic floor may cause one or more concentric indentation in 
urethral contour.  They are considered as normal variants.
A  neuropathic  bladder  may  closely  simulate  a  valve,  but  the  thin  stream below the 
obstruction will be seen emerging from the center of the external urethral sphincter rather 
than from posterior  margin as seen with a  valve.   In  such cases  the spine should be 
carefully examined and other evidence sought of a neurological deficit in perineum or 
lower limbs.  A posterior urethral stricture may cause a similar appearance but this will 
invariably be associated with history of urethral or pelvic trauma.
The Prune-Belly syndrome may closely mimic a valve, but the correct diagnosis should 
be suspected from the appearance of bladder which is horizontal and is invariably smooth 
walled, and the dog-leg configuration of posterior urethra which often bears a utriculus 
masculinus.A distended non-visualized ectopic ureter opening into ejaculatory duct may 
distort  and  partially  obstruct  the  posterior  urethra  thus  simulating  a  valve  .Whilst 
dilatation of the posterior urethra may also be caused by a prolapsed ectopic ureterocele 
or posterior polyp careful examination of these films however will usually reveal a filling 
defect leading to correct diagnosis4,11,24.
PRENATAL INTERVENTION
Is useful only for selected individuals and still experimental.  Only few cases have been 
tried but a price have to be paid, in the form of fetal loss and maternal morbidity. At 
present second or third trimester discovery of the obstructive process that begins and may 
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have  had  its  major  effects  in  the  first  trimester  rarely warrants  in-utero  intervention. 
Progressive bilateral hydronephrosis with worsening oligohydramnios detected in second 
trimester (21-28 weeks) may however be an indication.  When intervention is planned it 
is done in the tertiary centres. The potential for ECMO in those babies with borderline 
pulmonary hypoplasia is probably a treatment of the future.  Endoscopic vesico-amniotic 
shunting and fetal cystocopy are being experimented3,7,9.
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FETAL ULTRA SOUND
 
The dilated proximal urethra and dilated bladder (thickened) resembles a keyhole (arrow) 
extending from the bladder toward the fetal perineum
FETAL MRI 
Sagittal T2 view showing a dilated bladder (arrow) and proximal urethra (arrow). 
FETAL MRI
Sagittal T2 view showing the dysplastic right kidney (arrow) and urinary ascites (arrow). 
Note the oligohydramnios.
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INDIAN SCENARIO OF PUV
The incidence of antenatal diagnosis is only 10% in India.  Urinary diversion is done in 
50% of cases in most centers. In tertiary centres 80% of cases are ablated primarily . The 
results of laser fulguration of valves from AIIMS, New Delhi18 and the primary newborn 
fulguration from other centers in India are encouraging. Abraham from Kerala, Gopal 
from Varanasi and Kulasekar from Colombo have developed hooks for vale ablation but 
the use is limited to their own centers only31,32.  Fetal surgery is not done in any of our 
tertiary centres.
PRE OP PREPARATION
On suspicion 5 fr to 8 fr plastic infant feeding tube is inserted for continuous bladder 
drainage for selected patients. The self retaining catheter is avoided as the hypertrophied 
bladder tends to clamp down around the balloon and obstruct the ureters.  In our series we 
had to catheterize 20 of our patients immediately on admission.  One patient was referred 
with supra pubic cystostomy.
If the catheter is curled in the dilated PUV so that there is failure to drain, withdrawing 
the catheter for a few centimeters and repassing it with a finger in the rectum will usually 
ensure its  passage through the hypertrophied bladder  neck26.   Persistent  difficulty can 
usually be resolved by injecting a few ml of contrast medium through the catheter and 
manipulating it under fluoroscopic control.
Hyper kalemia and severe metabolic acidosis should be corrected. Hydration is assessed 
and in severe cases peritoneal dialysis is warranted as a resuscitative measure.  In our 
series peritoneal dialysis was done for 12 of our patients. 
As  a  routine,  blood  and  urine  culture  are  taken.   Then  amino  glycosides  or  third 
generation cephalosporin IV are started.  When in sepsis, blood coagulation studies are 
also carried out. Chest X-ray is taken in respiratory distress to exclude pneumothorax 
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secondary to pulmonary hypoplasia.  Even after this, if serum creatinine doesn't begin to 
fall percutaneous drainage of upper urinary tracts is considered.  MCU is done on the day 
of operation to confirm PUV and to detect if VUR is also present.  MCU in newborn is a 
major  procedure  and done under  strict  aseptic  precautions.   MCU is  skipped only in 
special situations where all information is obtained with ultra sound or radio isotope or 
rarely when baby is very sick and needs emergency diversion as a life saving procedure. 
MCU is done later when the baby's condition is stable.
MANAGEMENT PLAN
It  is a surgical  emergency, not like intestinal obstruction but cannot be delayed as an 
elective case.  Ideally treated within few days of diagnosis.  As mentioned earlier, we 
divided our patients into 3 groups. 
In Group – I
Once investigations were completed,  end fulguration was done.   MCU was done just 
before operation.  No need for pre-op IVF or bladder drainage.  35 patients were of this 
group. 
In Group – II
IV fluids  started  on  admission,  bladder  drained  using  5  fr  feeding  tube,  prophylactic 
antibiotics given and re-evaluation of the baby was done after 48 hours.  20 patients came 
under this group.  
Sub-Group-A  
Marked improvement in bio-chemical status,  MCU done just  before operation. 
Valve fulguration using endoscope was done. 12 patients came under this group.
Sub-Group-B 
No improvement, so urinary diversion like vesicostomy / ureterostomy was done. 
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8 patients came under this group.
In Group – III
Vesicostomy/ureterostomy was done as soon as resuscitation was completed and further 
treatment of valve was done after baby was stabilized.  46 patients came under this group. 
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In new born – IV antibiotics was given before any procedure.  In older children without 
urinary infection primary resection of valves and further surgery was considered later. 
Hendren et al performed total urinary tract re-construction in newborn period for patients 
with  severe  obstructive  uropathy  due  to  PUV  and  included  ureteral  tapering  and  re 
implantation.  Primary total re construction is generally abandoned nowadays because of 
high risk of obstruction associated with ureteral re impanation into thick and obstructed 
bladders.  
STEP LADDER PROTOCOL 25
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CYSTOSCOPE FOR FULGURATION
TECHNIQUE OF SURGICAL PROCEDURE – VALVE 
FULGURATION
The calibre of penile urethra should ideally be checked with a well lubricated 10 fr sound 
introduced for 1 to 2 cms26.  If necessary a 
meatotomy  can  be  performed  but  no 
attempt  should  be  made  to  dilate  the 
urethra.   Diagnosis  is  confirmed  using  a 
well lubricated 9.5 fr or 10fr.  Cystoscope 
introduced under vision.  
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Resection of valves is undertaken using a 6 fr  cystoscope fitted with bugbee electrode in 
newborns with the 3 F working channel4,11.  For older children 10 fr cystoscope is used. 
Some times a guidance wire is introduced through the 3F ureteric stent so that only the tip 
is exposed.  Instrument is first assembled and the alignment of working parts is checked 
using 0 degree telescope.  The sheath is then dried and thoroughly coated with water 
soluble  lubricant  and  with  introducer  in  place  is  gently  inserted  through  the  meatus. 
Introducer is now removed and the instrument is re assembled and gently advanced under 
vision towards the bladder neck.  It is frequently necessary to angle the eye piece end of 
the  instrument  downwards  to  allow the  beak  to  move  interiorly  to  pass  through  the 
bladder neck.  Once in the bladder the shape and position of ureteric orifices if possible 
are noted and presence of any periureteric diverticulum is noted.  
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The instrument is now rotated through 180 degrees and with irrigation flowing in under 
low pressure it is progressively withdrawn.  Once through the bladder neck, scope is run 
down along the anterior wall of posterior urethra until just beyond the veru, the valve will 
suddenly snap across the anterior portion of the field of view, like a curtain.  With further 
withdrawal of the instrument and manipulation the valve will be clearly seen.  A short 
burst of cutting current is then applied.
There is no need to excise the valves, but it is necessary to divide the valves at 2 points so 
that valvular obstruction is destroyed and urinary obstruction is removed.  We divide the 
valves at 2 points 5 and 7'O clock position.  In a rare instance of a diaphragm, we also 
divide the valve interiorly at two more sides 10 and 12'O clock positions.   Attempts to 
excise the valve leads to increased incidence of stricture formation.  Any remaining free 
floating tags do not require treatment.  It is  better to  under cut rather than over cut. 
Cystoscopy is now removed and the presence of unobstructed urethra is confirmed by 
manual expression of bladder (BUDDS TEST).  Finally a 8 fr feeding tube is passed and 
fixed  with  3/0  silk  suture  to  the  prepuce.   It  is  removed  after  24-48  hours.   If  any 
significant bleeding occurs,  attempts at  valve ablation is  discontinued and situation is 
reassesed after 2 to 3 days of catheter drainage.  In older children 10 fr cystoscopy is used 
employing similar technique.  
If urethra is too small for cystoscope some centers use perineal urethrostomy to  divide 
the  valves.   They also  use  a  trans  vesicle  route  using  angled  scope.  Others  use  9  fr 
examining scope (with an irrigation channel) and use an electrode or a ureteric catheter 
through the channel.
Antegrade valve ablation through an established vesicostomy or temporary percutaneous 
cystostomy,  has  been  described.   Neodymin –  Yag laser  energy instead  of  electrical 
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current  is  used.   Other  methods  of  valve  destruction  have  included  open  resection, 
pressure  necroses  from  an  indwelling  urethral  catheter,  destruction  by  dilatation  or 
fulguration through a perineal  urethrostomy or rupture of valve by a balloon catheter 
either Foleys or Fogarty.  In an improvement on an old theme, Whitaker has reintroduced 
the use of an insulated "Crochet Hook" type of instrument for blind valve ablation at 12'O 
clock position20. Using a similar approach, rupture of the valve has been accomplished 
blindly and without anesthesia using valvotome in a retrograde manner.  We have used 
check valvotome in 5 of our patients after fulguration under anaesthesia    We have also 
used check fogarty dilator for 10 of our patients.  Although direct endoscope ablation is 
preferable, the usefulness of these modifications is apparent.  
URINARY DIVERSION –VESICOSTOMY AND URETEROSTOMY
In  uraemic  and  infected  children  we  do  vesicostomy described  by  Blocksom in  our 
centre27,28 BLOCKSOM  VESICOSTOMY is  fashioned  through  a  small  transverse 
incision half way between the umbilicus and 
pubis.  The  fascia  is  incised  and  the 
peritoneum is pushed superiorly off the dome 
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of the bladder. The urachal remnant is divided and the dome of the bladder is pulled up to 
the skin. The fascia is secured to the bladder wall to form the required defect (No 22 Fr) 
and the bladder is matured as flush stoma.  We did vesicostomy primarily in 45 patients 
and secondarily in 1 patient.  
We did URETEROSTOMY primarily in 9 of our patients and secondarily in 2 patients. 
With infant in lateral decubitus position, a postero lateral oblique skin incision is made in 
the lower flank region.  Muscle layer is divided and retroperitoneum is entered.  Dilated 
tortuous ureter is identified and mobilized enough to reach the skin without tension and 
divided completely.  An infant feeding tube is passed proximally and distally to ensure 
that there are no angulations.  Then ureteral adventia is sutured to the external oblique 
fascia anteriorly and posteriorly.   Muscle and fascial layers are re approximated on both 
sides of exteriorized ureter.
POST OP TREATMENT- 48 HOURS 
IVF, antibiotics and bladder drainage is needed in immediate post  OP period.   These 
babies  developed  transient  diuretic  phase  following  release  of  obstruction  (Post 
obstructive diuretic phase) and urinary output may vary between 300 to 1000 ml or even 
more.  Adequate amount of IV fluids is necessary for 3 to 7 days depending upon status 
of upper tract. Bladder is catheterized for 3 to 5 days if necessary.  
A prophylactic dose of antibiotic usually trimethoprim – sulphamethoxazole is given for 1 
month to guard against infection in the healing posterior urethra.  This is continued for 6 
months in those infants who cystogram reveals VUR. Sodium bicarbonate supplements 
are also frequently necessary to correct a persistent metabolic acidosis and these may be 
continued for a year or more.  Polyuria is also common and parents are advised to give 
supplementary clear feeds early in the event of a diarrhoel illness.  
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FOLLOW – UP
We usually do urethral calibration if there is a stricture formation19. Then we do a post-op 
MCU 4 to 6 months after valve fulguration if warranted to confirm the adequate resection 
of valve and to determine if VUR still persists.  If adequate and if VUR has disappeared 
then the vesicostomy or ureterostomy closure is done.  If there is some massive reflux, 
that needs corrective surgery.  We have done anti reflux surgery in 2 cases.
AT 3 MONTHS 
The GFR of each kidney is measured by the slope clearance method using 99m TC DTPA 
if  needed, and an IVU carried out.   Also serum creatinine,  electrolytes and acid base 
status checked. We had to do DTPA in 4 of our patients for the consequences of PUV. 
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AT 6 MONTHS
MCU is done.  Normally in one-third cases , VUR disappears.  If VUR is still persistent 
99m TC DMSA done.  We have done DMSA for 6 patients.
PROBLEMS WE ENCOUNTERED AFTER INITIAL INTERVENTION
Reflux – seen in 50% of valve patients.  Spontaneous resolution of reflux expected in 
atleast 20% of these patients after valve ablation.  So a period of watchful waiting on 
prophylactic antibiotics warranted.  Reflux has been demonstrated to resolve upto 3 years 
after treatment.  
Indications for surgical  intervention during this  period include break -through UTI or 
massive reflux that interferes with the adequate emptying of system.  If re implantation is 
necessary  care  must  be  taken  to  avoid  problems  with  a  thick  walled  non  compliant 
bladder.  Post-op complication rates of persistent reflux or obstruction in the range of 15 
to 30% can be expected.  Trans uretero urethrostomy with a unilateral re implant and 
psoas  hitch  may  give  better  results..  Bladder  dysfunction  will  also  compromise  the 
results.  We had VUR in 22 patients and we have done 2 reimplantations and tried STING 
procedure in one patient.
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VALVES, UNILATERAL REFLUX, DYSPLASIA (VURD SYNDROME)
Ducket et al have emphasized this syndrome of renal dysplasia associated with unilateral 
reflux.  Spurious function on IVP or renal scan with delayed films may be misleading due 
to reflux.  When recognized one can avoid re-implantation of a non functioning system. 
This  syndrome  is  visualized  normally  in  left,  but  right  also  involved  some  times. 
Fortunately this seems to be an effective pressure relieving adaptation which protects the 
uninvolved side.  To improve voiding dynamics 
1) Nephrectomy but not Ureterectomy 
2) Unilateral loop Ureterostomy 
3) Ureterocystoplasty 
4) Trans Uretero Ureterostomy can be done.  
We have done 4 nephroureterectomies (2 open and 2 laparoscopic)  in our patients,  2 
ureterostomies and 1 ureterocystoplasty in our study.
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CMG IN VALVE BLADDER
UNSTABLE
HYPOCOMPLIANT
MYOGENIC FAILURE
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DOES THE VALVE BLADDER MATTER?
EVIDENCE FROM TRANSPLANTED KIDNEYS
The graph shows that renal transplant following PUV fare less well than other conditions 
2
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THE VALVE BLADDER
HYPOCOMPLIANT UNSTABLE MYOGENIC FAILURE
PATHO PHYSIOLOGY OF VALVE BLADDER 24
BLADDER DYSFUNCTION – VALVE BLADDER SYNDROME
Even after relief of obstruction, a significant number of patients will continue to have 
detrusor  thickening  and  poor  compliance.   Manifestations  of  this  problem  include 
persistent ureteral dilatation associated with full valve bladder syndrome, a physiological 
obstruction of ureters associated with bladder filling.4,11,25  Even in the absence of reflux, 
persistent ureteral dilatation secondary to poor compliance of thickened bladder wall can 
be  a  source  of  alarm.   When  bladder  is  empty  drainage  from  the  ureters  proceeds 
unimpeded.  This abruptly changes with filling of the poorly compliant bladder.  Impaired 
drainage  of  the  upper  tracts  can  be  demonstrated  with  ultra  sound,  with  relief  upon 
voiding or catheterization.   This valve bladder syndrome may be managed by complete 
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urinary tract emptying at least twice daily either with double or triple voiding regimen, or 
CIC along with timed voiding during the day.  The use of anticholinergics to reduce the 
adverse effects of bladder and ureter is also desirable.  Ureteral changes can be seen in 
approximately  30%  of  older  valve  patients.   Attempts  to  improve  the  radiographic 
appearance by tapered re-implantation surgery are too often not with disheartening results 
when bladder dysfunction is ignored.  That is why we had to augment one of our patients 
(ureterocystoplasty with mitrofanoff) and many are to follow5.
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1. TREATMENT OF VALVE BLADDER
1. HYPOCOMPLIANT (EARLY POST FULGURATION) 
POP OFF DIVERSIONS 
NIGHT DRAINAGE 
ANTICHOLINERGICS +/- CIC
2. HYPOCOMPLIANT ( LATE) 
AUGMENTATION
3. UNSTABLE 
ANTICHOLINERGICS +/- CIC
4. MYOGENIC FAILURE 
CIC AND NIGHT DRAINAGE
2. TREATMENT OPTIONS ACCORDING TO 
URODYNAMIC FINDINGS
1. BLADDER PRESSURE LESS THAN 20 cm H20 WITH VOLUME 
EQUAL TO 3-4 HR URINE OUTPUT THEN 3-4 HOURLY CIC WILL 
SUFFICE
2. LOW PRESSURE LEAKAGE 
DRUGS + CIC
3. HYPERREFLEXIA 
ANTICHOLINERGICS + CIC
4. POOR COMPLIANCE HIGH PRESSURE LEAKAGE 
AUGMENTATION + CIC
5. TOTALLY INCOMPETENT BLADDER NECK
BLADDER NECK PROCEDURE + AUGMENT + CIC (MITROFANOFF)
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URO DYNAMIC STUDY 
Shows leak due to gross instability. This is also causing gross reflux.  Hence bladder 
augmentation with reimplantation may be an option provided the Sr. creatinine remains 
stable (around 1.6 mg/dl now) and provided the patient is willing for self c.i.c.. 
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URINARY INCONTINENCE
This is common event when there has been no bladder neck surgery or sphincter damage 
is seen. Our review has 25% of urinary incontinence mostly minor.  Stricture or injury to 
external sphincter or bladder neck was not seen in our study.  Although urge incontinence 
improves at time of puberty presumably secondary to prostatic growth, this is not always 
the case.  Incontinence may be due to detrusor instability, increased urinary output (Fixed 
tubular concentrating defect secondary to previous obstruction) or inadequate sensation of 
a full bladder.  
Using formal  urodynamic  studies  15% of  valve population have  bladder  dysfunction, 
despite  successful  valve  ablation.   Bladder  Hypertonia  Hyperreflexia  and  Myogenic 
failure are the 3 main urodynamic findings and these may be overlapping in individual 
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LONG TERM BLADDER MANAGEMENT 
Urodynamic
 assessment
Anticholinergic
 drugs
Timed voiding
Augmentation
Night Drainage
patients.  
Day time urinary incontinence after the age 5 has been a consistent clinical sign in one-
third of patients with bad outcome regarding renal function. These findings serve as a 
warning for early attention to voiding dynamics. Simple relief of obstruction will alter the 
pathophysiology of the condition in most patients, but sophisticated intervention for the 
persistent effects caused by secondarily hyper trophied bladder may be necessary.  Many 
of the method now used to control the neurogenic bladder are applicable including CIC, 
anticholinergics, bladder augmentation with bowel or more recently auto augmentation by 
creating  a  large  bladder  diverticulum  to  lower  the  high  bladder  pressure  and  night 
drainage.  In our series one patient underwent augmentation with Mitrofanoff. 
Patients  with  ESRD awaiting transplant  must  have their  bladders  evaluated  carefully. 
Failure to address and correct under lying bladder dysfunction could result in ureteral 
obstruction, reflux, infection or even graft loss.  
CHRONIC RENAL FAILURE
About 10% of patients with PUV will be stillborn or not survive the neonatal period. 
Ultimately upto 35% of children with PUV will develop some degree of CRF, generally 
associated with azotemia, anemia and acidosis.  A more precise operational definition is 
renal insufficiency for more than 3 months with evidence of decreased GFR, anemia, 
osteodystrophy and electrolyte disturbances.  However transplanted valve patient do not 
do  well  when  compared  to  transplanted  patients  with  other  causes  of  renal  failure. 
Abnormal bladder dynamics may play a role but clearly more study is warranted.  In our 
study nearly 40 percent of our children developed chronic renal failure.
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AUGMENTATION (URETEROCYSTOPLASTY) 
WITH MITROFANOFF PROCEDURE 
NIGHT DRAINAGE
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ULTRASOUND – VOIDING PROGRAMME
BEFORE 
6 MONTHS LATER
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SEXUAL FUNCTION AND FERTILITY 
Kruger reported an increased incidence of UDT in 12% of PUV patients. 2 patients had 
UDT in our study. A recent study indicates that the number of spermatogonia in fetuses 
with PUV and prune-belly syndrome are decreased when compare to a control group of 
normal fetuses.  Wood house et al reported no evidence of testicular or sexual dysfunction 
in 20 adults originally treated for PUV.  Hence there was a high incidence of retrograde 
ejaculation and poor ejaculatory force, suggesting persistent bladder neck incompetence. 
Previously undiagnosed PUV in adults have been reported in infertility patients.  These 
studies emphasis sterility from retained ejaculate in dilated PU and symptoms of chronic 
prostatitis  and  bladder  neck  contracture  in  others.   Adult  PUV  presentation  remains 
infrequent.
LONG TERM
Prognosis depends upon
1. Presence of renal dysplasia before birth.
2. Status of upper tracts on admission.
3. Presence of infection.
4. Upon the presence or absence of VUR.
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All  infants and those older  children with impaired renal  function at  presentation will 
require  close  supervision  until  adult  life  is  reached.   A  progressive  rise  in  serum 
creatinine is often seen during childhood and in most severe cases renal transplantation 
may  be  required  before  puberty.  Persistent  urinary  incontinence  is  an  indication  for 
cystometrogram.  Bladders showing severe hyperreflexia or very poor compliance may 
require augmentation prior to transplantation. At present none of our patients required 
renal transplantation.
In the antenatally diagnosed children in our study out of 8 patients, 7 of them had either 
mortality or morbidity in them.  Only one patient is at present without problems.  So the 
prognosis of antenatally detected patients has been dismal in our study.
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CONCLUSION
By means of this study the following conclusions were arrived at  
1. Though technically demanding primary fulguration seems to be a promising method 
for managing PUV irrespective of age. The benefits of primary fulguration are:
a. Length of hospital stay is reduced 
b. Cost effective 
c. Lesser number of surgeries
d. Scarless
e. Parent's psychological trauma is lessened
2. We could avoid urinary diversion in 42.30 percentage of our cases. 
3. Urosepsis  and  increased  serum  creatinine  are   not  absolute  contraindications  for 
primary fulgurations
4. Outcome  of  patients  with  PUV  depends  upon  initial  renal  status  irrespective  of 
management options used
5. So it is better to fulgurate as a single stage than going in for diversion which involves 
many stages
6. The prognosis of antenatally detected patients was dismal in our study.
7. Patients should be referred at the earliest to tertiary centres which have facilities for 
fulguration
8. Long  term  follow-up  is  a  must  going  by  the  prognostic  indicators  with  special 
attention to bladder dynamics.
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PROFORMA
Name : Age : I.P. No.
Symptoms: Dribbling D.O.A :
Failure to thrive D.O.S :
Vomiting D.O.D :
AN Detected 
Others
Duration of Symptoms :
Treatment Obtained : Yes / No
AN History  - Delivery :
Consanguinity :
AN Scan :
Significant AN problem:
Family History :
Examination :
Investigations : Bl. Urea :
S. Creatinine :
Bl. Sugar :
USG Abd :
MCU :
Treatment Given : Primary Fulguration
Diversion
Follow-up
70
Bl.Urea :
S.Creatinine :
Hb% :
Urine RE :
Urine C/s :
USG abd (Residual Urine) :
MCU :
Outcome : 
71
MASTER CHART P.U.V PATIENTS
S. 
NO NAME AGE DOS PRI. TRT.
SEC. 
TRT OTHERS
OUTC
OME
1 B/o 
Manonmani
2 mon. 1-1-98 b/l ureterostomy --------- vur expired
2 Raghavendran 2 yrs 28-3-98 vesicostomy Cyst.fulg Seizures
catheterised
ok
3 Sudarshan 1 mon 14-5-98 vesicostomy -------- No fu
4 Daniel 4.5 yrs 26-3-99 Rt ureterostomy Cyst.fulg ok
5 B/o Poomany 22 days 24-4-99 vesicostomy No fu
6 Devaraj 3yrs 15-7-99 vesicostomy Cyst.fulg Ok
7 Joshua 1yr 30-4-99 vesicostomy Cyst.fulg ok
8 Gurupriya 13 days 13-8-99 vesicostomy catheterised No fu
9 Pommudurai 6yrs 31-8-99 b/l ureterostomy Cyst.fulg Stricture
Dilatation
ok
10 B/o rani 30 days 24-9-99 vesicostomy catheterised No fu
11 yoshua 10 days 20-8-96 vesicostomy Cyst.fulg ok
12 kumar 6yrs 29-10-99 vesicostomy Cyst.fulg Stricture 
dilatation
ok
13 B/o vijaya 4 days 24-11-99 vesicostomy expired
14 arulmani 10yrs 26-11-99 Cyst.fulg ok
15 ramu 5yrs 30-5-00 vesicostomy Cyst.fulg ok
16 B/o krishnaveni 15 days 19-6-05 ------- ------ Peritoneal 
dialysis
expired
17 hariharan 8 mon 12-8-00 vesicostomy No fu
18 murugan 8yrs 19-9-00 b/l ureterostomy Cyst.fulg Stricture 
dilatation
ok
19 vadivelu 7yrs 13-10-00 b/l ureterostomy Cyst.fulg Vur ok
20 Pradeep kumar 3yrs 17-10-00 vesicostomy Cyst.fulg No fu
21 jeevanathan 5yrs 14-11-00 vesicostomy Cyst.fulg No fu
22 harinarayanan 9yrs 30-1-01 Cyst.fulg crf Ok
23 murugan 7yrs 21-6-01 Cyst.fulg Ok
24 B/o anandhi 2 mon 21-6-01 vesicostomy Cyst.fulg catheterised ok
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25 Jeevanathan 5yrs 22-6-01 vesicostomy Cyst.fulg ok
26 Arunprasad 9 mon 4-7-01 vesicostomy Cyst.fulg vur ok
27 B/o Elizabeth 7days 14-7-01 vesicostomy Antenatal 
diagnosis
expired
28 Kadar basha 5yrs 14-9-01 b/l ureterostomy Cyst.fulg Vur ok
29 Amen akbar 12yrs 18-9-01 Cyst.fulg ok
30 B/o sunitha 4days 4-12-01 vesicostomy Lost fu
31 Mohan 2yrs 11-12-01 Cyst.fulg ok
32 Binnikumar 11month
s
14-1-02 vesicostomy Vur expired
33 Rahamatullah 62days 26-1-02 vesicostomy Vur catheterised expired
34 Sabi 4yrs 14-2-02 Cyst.fulg ok
35 Sanjeevi 6months 8-4-02 vesicostomy Vur peri.dial. expired
36 B/o 
Maragatham
21days 2-5-02 vesicostomy Cyst.fulg ok
37 B/o Maheswari 41 days 17-5-02 b/l ureterostomy Cyst.fulg Fungal ball 
nephrectomy
ok
38 Sankar 4 mon 14-7-02 vesicostomy Cyst.fulg Vur Lost fu
39 Gunalan 4 mon 9-8-02 vesicostomy Vur expired
40 Premkumar 4 mon 30-8-02 Cyst.fulg Catheterized vur ok
41 Yuvan 2.5 yrs 3-9-02 Cyst.fulg Catheterized vur ok
42 Murugesan 12yrs 30-9-02 Cyst.fulg Vur ok
43 Gunasekaran 10 mon 20-9-02 Cyst.fulg ok
44 B/o Ellamal 2 days ------ ----- expired
45 Ramesh 2.5 yrs 22-10-02 vesicostomy Cyst.fulg. ok
46 B/o Madammal 17 days 30-10-02 Cyst.fulg catherised ok
47 B/o Tamilselvi 1day 13-11-02 vesicostomy Antenatal diag. 
vur
Lost fu
48 Nagendran 1yr 11-12-02 vesicostomy Cyst.fulg Lost fu
50 Guna 3.5 yrs 30-5-03 vesicostomy Peri.dial. Lost fu
51 Anilkumar 1yr 3-6-03 vesicostomy Cyst fulg hepatoblastoma expired
52 B/o Karpayee 12 days 25-7-03 vesicostomy Cyst fulg Epi.orchi ok
53 Saravanan 50 days 1-8-03 Cyst. fulg catheterised ok
54 B/o suguna 1day 12-8-03 Cyst fulg catheterised Ok
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55 Gokul 30 days 16-9-03 Cyst fulg Type 3 Ok
56 Binnykumar 11 mon 30-9-03 vesicostomy Cyst fulg ok
57 Raja 3.5 yrs 2-12-03 vesicostomy Peri. dial expired
58 Dhinu 1.5 10-2-04 Cyst fulg Peri dial 
catheterised
Lost fu
59 B/o Loganayagi 4 mon 10-3-04 Cyst fulg calculi ok
60 Vignesh 1.5yr 2-3-04 Lt ureterostomy Cyst fulg Vur ok
61 B/o Sarojini 4 mon 17-3-04 Cyst fulg Catheterized 
ante.diag.
ok
62 B/o 
Krishnaveni
28 days 24-3-04 Cyst fulg Spc 
ante.diag.peri.di
al
Lost fu
63 Ganesan 12yrs 24-3-04 Cyst fulg Catheterized 
-cvs -c rf
Lost fu
64 Guhan 4 mon 6-4-04 Cyst fulg vesicosto
my
catheterised Lost fu
65 Bharathi 3 mon 27-6-04 vesicostomy Cyst fulg Lost fu
66 Udhayakumar 3 mon 3-8-04 Cyst fulg Type 3 Ok
67 Om prakash 2yrs 20-7-04 vesicostomy Cyst fulg ok
68 B/o Kalaivani 16 days 24-9-04 vesicostomy Cyst fulg Peri.dial. Ok
69 B/o 
Padmapriya
10 days 14-12-04 Cyst fulg Ok
70 Lalith 1yr 17-12-04 Cyst fulg Peri.dial.-crf Ok
71 Mohideen 
Basha
1yr 4-1-05 Cyst fulg Vur Ok
72 Joyal Vinith 25 days 5-1-05 Cyst fulg Ok
73 Mohamed Iqbal 5 days 19-1-05 Cyst fulg Ok
74 B/o 
Ranjanadevi
6 days 1-2-05 Cyst fulg ok
75 B/o Anish 
Fathima
1 day 2-2-05 Cyst fulg Ante,diag.-ing 
hernia
Expired
76 B/o Usha 27 days 1-2-05 Cyst fulg Ok
77 Akash 1yr 19-4-05 b/l ureterostomy Cyst fulg ok
78 Devaraj 9yrs 20-5-05 vesicostomy Cyst fulg Ok
79 Magesh 
Kannan
8 mon 10-5-05 vesicostomy Cyst fulg Ok
80 Wilson 1.5yr 15-7-05 vesicostomy valvotomy Vur –p.d. Ok
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deafmute-
cataract
81 Vignesh 2.5yrs 9-8-05 Cyst fulg Ok
82 Pommudurai 12yr 12-8-05 b/l ureterostomy Cyst fulg Str.dil.-reimpl.-
nephrect
Ok
83 Mohan 6 mon 30-8-05 vesicostomy Cyst fulg expired
84 Thilak 10yrs 8-11-05 Cyst fulg fogarty Ok
85 Jay Pratap 2yr 22-11-05 vesicostomy Cyst fulg Vur-
ante.diag.nephre
ct
Ok
86 Ashwin 1.5yr 16-12-05 Cyst fulg b/l udt Ok
87 B/o.Radha 18 days 27-12-05 Cyst fulg Catheterized-
p.d.
Ok
88 Arulmani 2.5 yrs 12-1-06 vesicostomy Cyst fulg p.d.-crf Ok
89 Sankaran 10yrs 31-1-06 vesicostomy Cyst fulg Ok
90 B/o.Sowmya 22 days 14-2-06 Cyst fulg Valvotome-
vur-?vurd
Ok
91 B/o Abirami 2 days 10-1-02 vesicostomy vur Lost fu
92 B/o.Dhanalaksh
mi
1day 7-3-06 Cyst fulg Valvotome-vur-
ant.diag.
Ok
93 B/o.Nagamani 7 days 2-5-06 Cyst fulg Ok
94 Gowrishankar 10 mon 29-8-06 Cyst fulg Sting tried 
reimpl.
Ureterocele-
ant.diag.-vur
ok
95 Arunkumar 5yrs 1-12-06 Cyst fulg vesicosto
my
Vur-
catheterised
ok
96 B/o.Veerammal 19 days 2-1-07 Cyst fulg Vur-
catheterised-
valvotome
ok
97 B/o.Maheswari 10 days 17-9-04 Cyst fulg Vent.hernia ok
98 B/o.Chamundes
wari
12 days 21-6-94 b/l ureterostomy Cyst fulg ok
99 B/o.Sangeetha 2 days 22-4-05 Cyst fulg Urachal cyst expired
100 B/o Jaya 17 days 9-1-07 Cyst fulg Valvotome-
cathe
ok
101 Venkatesh 4 mon 2-2-06 Cath.-p.d-crf. expired
102 Krishnaveni 26 days 22-12-05 crf expired
103 Santhosh 
Kumar
5yrs 3-1-07 ?cyst fulg ok
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104 Dhandapani 20 days 29-12-94 Vesicostomy Cyst fulg Augmentation-
mitrofanoff-
nephrectomy
ok
76
